• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

多发性骨髓瘤的生活质量与支持性护理

Quality of life and supportive care in multiple myeloma.

作者信息

Cömert Melda, Güneş Ajda Ersoy, Sahin Fahri, Saydam Güray

机构信息

Ege University School of Medicine, Department of Hematology, İzmir, Turkey.

出版信息

Turk J Haematol. 2013 Sep;30(3):234-46. doi: 10.4274/Tjh.2012.0192. Epub 2013 Sep 5.

DOI:10.4274/Tjh.2012.0192
PMID:24385802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3878535/
Abstract

UNLABELLED

Multiple myeloma is the second most common haematological malignancy. Novel therapies have led to improvement in survival. Current myeloma management is matching the progress made in improved survival through disease control while optimising quality of life with effective supportive care. Supportive treatment is an essential part of the therapeutic management of myeloma patients because it is directed towards improving the patient's quality of life and also can improve survival. The aim of this review is to highlight the relationship among life of quality, supportive care, and improvement in survival.

CONFLICT OF INTEREST

None declared.

摘要

未标注

多发性骨髓瘤是第二常见的血液系统恶性肿瘤。新型疗法已使生存率得到提高。目前的骨髓瘤管理在通过疾病控制实现生存率提高的同时，还通过有效的支持性护理优化生活质量，二者齐头并进。支持性治疗是骨髓瘤患者治疗管理的重要组成部分，因为它旨在提高患者的生活质量，也有助于提高生存率。本综述的目的是强调生活质量、支持性护理与生存率提高之间的关系。

利益冲突

未声明。

相似文献

1
Quality of life and supportive care in multiple myeloma.多发性骨髓瘤的生活质量与支持性护理
Turk J Haematol. 2013 Sep;30(3):234-46. doi: 10.4274/Tjh.2012.0192. Epub 2013 Sep 5.
2
[Current approaches to supportive care in multiple myeloma].[多发性骨髓瘤支持性护理的当前方法]
Srp Arh Celok Lek. 2011 Dec;139 Suppl 2:123-8. doi: 10.2298/sarh11s2123g.
3
Supportive care in multiple myeloma.多发性骨髓瘤的支持性护理。
Clin Lymphoma Myeloma. 2006 Jul;7(1):42-50. doi: 10.3816/CLM.2006.n.038.
4
Guidelines for supportive care in multiple myeloma 2011.多发性骨髓瘤支持治疗指南 2011 年版
Br J Haematol. 2011 Jul;154(1):76-103. doi: 10.1111/j.1365-2141.2011.08574.x. Epub 2011 Apr 22.
5
Supportive Care in Multiple Myeloma.多发性骨髓瘤的支持性护理。
Curr Hematol Malig Rep. 2020 Apr;15(2):56-61. doi: 10.1007/s11899-020-00570-9.
6
Multiple myeloma in the elderly.老年人多发性骨髓瘤
J Am Geriatr Soc. 1994 Jun;42(6):653-64. doi: 10.1111/j.1532-5415.1994.tb06866.x.
7
Underutilization of guideline-recommended supportive care among older adults with multiple myeloma in the United States.美国老年多发性骨髓瘤患者中指南推荐的支持性护理未得到充分利用。
Cancer. 2019 Nov 15;125(22):4084-4095. doi: 10.1002/cncr.32428. Epub 2019 Aug 5.
8
Multiple Myeloma: New Insights and Therapeutic Approaches.多发性骨髓瘤：新见解与治疗方法
Hematology Am Soc Hematol Educ Program. 2000:147-165. doi: 10.1182/asheducation-2000.1.147.
9
Review of Myeloma Therapies and Their Potential for Oral and Maxillofacial Side Effects.骨髓瘤治疗方法及其对口腔颌面副作用的潜在影响综述。
Cancers (Basel). 2021 Sep 6;13(17):4479. doi: 10.3390/cancers13174479.
10
Challenges in the cultural adaptation of the German Myeloma Patient Outcome Scale (MyPOS): an outcome measure to support routine symptom assessment in myeloma care.德国多发性骨髓瘤患者结局量表（MyPOS）文化调适的挑战：一种支持多发性骨髓瘤护理常规症状评估的结局指标。
BMC Cancer. 2020 Mar 23;20(1):245. doi: 10.1186/s12885-020-06730-7.

引用本文的文献

1
Epidemiology of patients treated for multiple myeloma using a new algorithm in the French national health insurance database (SNDS): Results from the MYLORD study.在法国国家健康保险数据库（SNDS）中使用新算法治疗的多发性骨髓瘤患者的流行病学：MYLORD研究结果
PLoS One. 2025 May 8;20(5):e0322474. doi: 10.1371/journal.pone.0322474. eCollection 2025.
2
Experiences of Multiple Myeloma Patients With Treatment in the Palestinian Practice: A Multicenter Qualitative Study in a Resource-Limited Healthcare System.巴勒斯坦多发性骨髓瘤患者的治疗经历：资源有限的医疗保健系统中的多中心定性研究。
Cureus. 2024 Jun 28;16(6):e63365. doi: 10.7759/cureus.63365. eCollection 2024 Jun.
3

本文引用的文献

1
Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM-comorbidity score.合并症作为多发性骨髓瘤的预后变量：常用合并症评分的比较评估和新型 MM 合并症评分的应用。
Blood Cancer J. 2011 Sep;1(9):e35. doi: 10.1038/bcj.2011.34. Epub 2011 Sep 16.
2
Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registry.多发性骨髓瘤患者诊断后 10 年内的健康相关生活质量和疾病特异性投诉：使用 PROFILES 登记处进行的基于人群的研究结果。
Eur J Haematol. 2012 Oct;89(4):311-9. doi: 10.1111/j.1600-0609.2012.01831.x. Epub 2012 Aug 1.
3
Multiple myeloma with presentation in the oral cavity.
口腔表现的多发性骨髓瘤。
J Oral Maxillofac Pathol. 2022 Jan-Mar;26(1):104-107. doi: 10.4103/jomfp.jomfp_377_21. Epub 2022 Mar 31.
4
Consensus Statement: Importance of Timely Access to Multiple Myeloma Diagnosis and Treatment in Central America and the Caribbean.共识声明：中美洲和加勒比地区及时获得多发性骨髓瘤诊断和治疗的重要性
J Hematol. 2022 Feb;11(1):1-7. doi: 10.14740/jh971. Epub 2022 Feb 26.
5
Cost-effectiveness of adding daratumumab or bortezomib to lenalidomide plus dexamethasone for newly diagnosed multiple myeloma.来那度胺联合地塞米松添加达雷妥尤单抗或硼替佐米治疗新诊断多发性骨髓瘤的成本效果分析。
J Manag Care Spec Pharm. 2021 Dec;27(12):1691-1702. doi: 10.18553/jmcp.2021.27.12.1691.
6
[Not Available].[无可用内容]
Can Oncol Nurs J. 2021 Nov 1;31(4):430-450. doi: 10.5737/23688076314430450. eCollection 2021 Fall.
7
Supportive care interventions and quality of life in advanced disease prostate cancer survivors: An integrative review of the literature.晚期前列腺癌幸存者的支持性护理干预与生活质量：文献综合综述
Can Oncol Nurs J. 2021 Nov 1;31(4):412-429. doi: 10.5737/23688076314412429. eCollection 2021 Fall.
8
Initial Therapeutic Approaches to Patients with Multiple Myeloma.多发性骨髓瘤患者的初始治疗方法。
Adv Ther. 2021 Jul;38(7):3694-3711. doi: 10.1007/s12325-021-01824-5. Epub 2021 Jun 18.
9
HDAC6-Selective Inhibitor Overcomes Bortezomib Resistance in Multiple Myeloma.组蛋白去乙酰化酶 6 选择性抑制剂克服多发性骨髓瘤硼替佐米耐药。
Int J Mol Sci. 2021 Jan 29;22(3):1341. doi: 10.3390/ijms22031341.
10
Smoldering multiple myeloma revealed by superior ophthalmic vein thrombosis.
Saudi J Ophthalmol. 2020 Nov 22;34(1):62-65. doi: 10.4103/1319-4534.301163. eCollection 2020 Jan-Mar.
Bisphosphonates in multiple myeloma: a network meta-analysis.
双膦酸盐类药物治疗多发性骨髓瘤：一项网状Meta分析
Cochrane Database Syst Rev. 2012 May 16(5):CD003188. doi: 10.1002/14651858.CD003188.pub3.
4
Content development for the Functional Assessment of Cancer Therapy-Multiple Myeloma (FACT-MM): use of qualitative and quantitative methods for scale construction.癌症治疗功能评估-多发性骨髓瘤量表（FACT-MM）的内容开发：使用定性和定量方法进行量表构建。
J Pain Symptom Manage. 2012 Jun;43(6):1094-104. doi: 10.1016/j.jpainsymman.2011.06.019. Epub 2012 May 9.
5
Myeloma: diagnosis complications and supportive care.骨髓瘤：诊断、并发症及支持治疗
Hematology. 2012 Apr;17 Suppl 1:S109-11. doi: 10.1179/102453312X13336169156177.
6
Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: results from the VISTA trial.老年初诊多发性骨髓瘤患者采用 VMP 与 MP 治疗的健康相关生活质量：VISTA 试验结果。
Eur J Haematol. 2012 Jul;89(1):16-27. doi: 10.1111/j.1600-0609.2012.01788.x. Epub 2012 May 7.
7
Efficacy, safety and quality-of-life associated with lenalidomide plus dexamethasone for the treatment of relapsed or refractory multiple myeloma: the Spanish experience.来那度胺联合地塞米松治疗复发或难治性多发性骨髓瘤的疗效、安全性和生活质量：西班牙经验。
Leuk Lymphoma. 2012 Sep;53(9):1714-21. doi: 10.3109/10428194.2012.662643. Epub 2012 Mar 1.
8
Quality of life assessment in multiple myeloma patients undergoing dose-reduced tandem autologous stem cell transplantation.接受减低剂量 tandem 自体干细胞移植的多发性骨髓瘤患者的生活质量评估。
Mediterr J Hematol Infect Dis. 2011;3(1):e2011057. doi: 10.4084/MJHID.2011.057. Epub 2011 Nov 28.
9
Autologous stem cell transplantation improves quality of life in economically challenged, Brazilian multiple myeloma patients.自体干细胞移植可提高经济困难的巴西多发性骨髓瘤患者的生活质量。
Clinics (Sao Paulo). 2011;66(11):1855-9. doi: 10.1590/s1807-59322011001100002.
10
Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network.各亚型血液恶性肿瘤的发病情况：来自血液恶性肿瘤研究网络的报告。
Br J Cancer. 2011 Nov 22;105(11):1684-92. doi: 10.1038/bjc.2011.450. Epub 2011 Nov 1.